SHUKRA PHARMACEUTICALS
Back to Income Statement
|
SHUKRA PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹33 Cr | ₹75 Cr | ₹59 Cr | ₹20 Cr | ₹11 Cr |
What is the latest Revenue of SHUKRA PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹33 Cr |
| Mar2024 | ₹75 Cr |
| Mar2023 | ₹59 Cr |
| Mar2022 | ₹20 Cr |
| Mar2021 | ₹11 Cr |
How is Revenue of SHUKRA PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹33 Cr | -56.30 | |
| Mar2024 | ₹75 Cr | 26.75 | |
| Mar2023 | ₹59 Cr | 187.19 | |
| Mar2022 | ₹20 Cr | 82.98 | |
| Mar2021 | ₹11 Cr | - | |
Compare Revenue of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹2,343.2 Cr | 13.1% | -5.1% | 171.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | 13.1% |
-5.1% |
171.6% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses